The largest database of trusted experimental protocols

Scintillation fluid

Manufactured by Thermo Fisher Scientific
Sourced in United States

Scintillation fluid is a specialized liquid used in the detection and measurement of radioactivity. It is designed to interact with ionizing radiation, such as alpha, beta, or gamma particles, and convert the energy into light that can be detected by a scintillation counter. The scintillation fluid is a key component in various analytical techniques involving radioactive materials.

Automatically generated - may contain errors

8 protocols using scintillation fluid

1

Radiolabeled Neurotransmitter Uptake Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments using animal subjects were conducted according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. All experiments involving animal subjects were conducted as preapproved by Drexel University Institutional Animal Care and Use Committees. Radio-labeled substrates, [3H]-dopamine (32.6 Ci/mmol) and [3H]-serotonin (23.9 Ci/mmol), were purchased from PerkinElmer (Boston, MA). Cell culture media and supplements, including penicillin/streptomycin, Dulbecco’s phosphate-buffered saline (D-PBS), Dulbecco’s modified Eagle’s medium (DMEM) with glucose, and scintillation fluid, were obtained from Thermo Fisher Scientific (Waltham, MA). Transfection reagents TransIT-LT1 and LipoJet reagent were from Mirus Bio LLC (Madison, WI) and SignaGen Laboratories (Rockville, MD), respectively. Reagents for uptake assays and nonradiolabeled substrates were purchased from Sigma-Aldrich (St. Louis, MO). MTSEA-biotin was purchased from Biotium, Inc. (Fremont, CA). Reagents for uptake assays and nonradiolabeled substrates were purchased from Sigma-Aldrich (St. Louis, MO).
+ Open protocol
+ Expand
2

Radioactive Uptake Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sydnocarb was a gift from Teva Pharmaceuticals (Frazer, PA, USA). Radiolabeled substrates, [3H]-dopamine (32.6 Ci/mmol) and [3H]-serotonin (23.9 Ci/mmol), were purchased from PerkinElmer (Boston, MA, USA). Cell culture media and supplements, including penicillin/streptomycin, Dulbecco’s phosphate-buffered saline (DPBS), Dulbecco’s modified Eagle’s medium (DMEM) with glucose, and scintillation fluid, were obtained from Thermo Fisher Scientific (Waltham, MA, USA). Transfection reagents TransIT-LT1 and LipoJet reagent were from Mirus Bio LLC (Madison, WI, USA) and SignaGen Laboratories (Rockville, MD, USA), respectively. Reagents for uptake assays and non-radiolabeled substrates were purchased from Sigma-Aldrich (St. Louis, MO, USA). MTSEA-biotin was purchased from Biotium, Inc. (Fremont, CA, USA). Reagents for uptake assays and non-radiolabeled substrates were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
3

Measuring Protein Synthesis in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Equal numbers of cells were plated in 6-well plates (~2–3 × 105 cells/well) and allowed to attach overnight. Cells were exposed to bortezomib (30nM) or cycloheximide (20μM) as indicated. Following incubation, drugs were removed and cells were pulsed for 1–2 hours with 1 μCi/mL L-[4,5- 3H(N)] leucine (Perkin-Elmer, Waltham, MA) in leucine-free media (MP Biomedicals, Solon, OH) supplemented with 10% dialyzed FBS, vitamins, L-glutamine, antibiotics, and HEPES. Cells were trypsinized and pellets lysed in a 1% Triton X-100 buffer containing 25mM Tris-HCl, 300mM NaCl, and 10mM PMSF plus complete protease inhibitors by rotation for 20–30 minutes at 4° C. Lysates were clarified via centrifugation and proteins were precipitated overnight at 4° C in 5% trichloroacetic acid (TCA). The resulting precipitates were collected via centrifugation and dissolved in 0.1% KOH. Samples were aliquoted in triplicate and combined with scintillation fluid (ThermoFisher Scientific, Waltham, MA). CPMs were measured by a Beckman Coulter LS6500 scintillation counter.
+ Open protocol
+ Expand
4

Measuring Protein Synthesis in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Equal numbers of cells were plated in 6-well plates (~2–3 × 105 cells/well) and allowed to attach overnight. Cells were exposed to bortezomib (30nM) or cycloheximide (20μM) as indicated. Following incubation, drugs were removed and cells were pulsed for 1–2 hours with 1 μCi/mL L-[4,5- 3H(N)] leucine (Perkin-Elmer, Waltham, MA) in leucine-free media (MP Biomedicals, Solon, OH) supplemented with 10% dialyzed FBS, vitamins, L-glutamine, antibiotics, and HEPES. Cells were trypsinized and pellets lysed in a 1% Triton X-100 buffer containing 25mM Tris-HCl, 300mM NaCl, and 10mM PMSF plus complete protease inhibitors by rotation for 20–30 minutes at 4° C. Lysates were clarified via centrifugation and proteins were precipitated overnight at 4° C in 5% trichloroacetic acid (TCA). The resulting precipitates were collected via centrifugation and dissolved in 0.1% KOH. Samples were aliquoted in triplicate and combined with scintillation fluid (ThermoFisher Scientific, Waltham, MA). CPMs were measured by a Beckman Coulter LS6500 scintillation counter.
+ Open protocol
+ Expand
5

Radioactive Glutamate Uptake Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Materials 3 H-L-glutamate (51.1 Ci/mmol) was purchased from PerkinElmer (Boston, MA, USA). Cell culture media included Dulbecco's modified Eagle's medium with glucose, fetal bovine serum, penicillin/streptomycin, glutamine, and phosphate-buffered saline (D-PBS) were obtained from Corning Cellgro (Manassas, VA, USA). Transfection reagent TransIT-LT1 was from Mirus Bio LLC (Madison, WI, USA). Reagents for uptake assays and nonradiolabeled substrates were purchased from Sigma-Aldrich (St. Louis, MO, USA). Scintillation fluid was from Thermo Fisher Scientific (Waltham, MA, USA).
+ Open protocol
+ Expand
6

Plasma Tracer Concentration Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described previously [25 (link)], plasma (35–300 μL) was separated from each blood sample after centrifugation and transferred to a glass vial preloaded with scintillation fluid (Fisher Chemical, Waltham, MA, USA). The tracer concentration in the plasma and dose 3H content was then measured by liquid scintillation spectrometry (Beckman Coulter, Brea, CA, USA) to a 2-sigma error of 1% or for a maximum of 300 min.
+ Open protocol
+ Expand
7

Estrogen Receptor Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
96-well microtiter filter plates (Millipore, USA) were used in the assay. Each compound was diluted with 1:1 dimethylsulf- oxide assay buffer (50 mM Tris, 10% glycerol, pH 8.0, 0.3 mg/ml ovalbumin, 0.01 M mercaptoethanol) to seven concentrations from 7 × 10–11 M to 7 × 10–5 M. 10 μl compound dilutions, 10 μl 3[H]E2 (7 × 10–8 M) and 50 μl recombinant ER protein (1.0 × 10–9 M) (PanVera/Invitrogen Corp, Carlsbad, USA) were loaded into each well. The plates were shaken in an orbital shaker for 5 min and incubated overnight (18–24 h) on ice. HAP slurry (Bio- Rad Pacific Ltd., USA) was added and incubated for 15 min at 0°C to capture the protein. The trapped proteins were washed twice with ice cold HAP washing buffer and re-suspended in HAP washing buffer. Portions of the solution were mixed with scintillation fluid (Fisher Scientific, USA) and subjected to measurement by a liquid scintillation counter (Beckman LS6500 Scintillation Counter, USA). The radioactivity of each sample was expressed as disintegration per minute (dpm). The binding of 3[H]E2 to ER in the presence of competitor was determined by subtracting the non-specific binding and expressed as percentage of total binding without competitor. The relative binding affinities (RBA) were calculated by (IC50 17β-estradiol/IC50 compound) × 100.
+ Open protocol
+ Expand
8

Immune Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immune cells in supplemented complete RPMI 1640 were plated in 96-well, flat-bottom plates (Falcon, Oxnard, CA, USA) at 2 × 105 cells/well in triplicate without further stimulation. In this study, additional immune challenge was omitted to better mimic in vivo disease conditions. Cultures were maintained for 72 h in a humidified, 7% CO2 incubator at 37°C. [3H]Thymidine (0.5 μCi/10 μl; Amersham, Arlington Heights, IL, USA) was added the last 24 h of culture. Cells were harvested onto glass fiber filters (Brandel, Gaithersburg, MD, USA) using a cell harvester (Brandel, Gaithersburg, MD, USA). The filters were placed in 5 ml of scintillation fluid (Fisher Scientific, Tustin, CA, USA), and [3H]Thymidine incorporation was determined using a liquid scintillation counter (Beckman, Brea, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!